Javlin has invested more than $480 million since 2011.

Healthcare Finance[wpsr_addthis type=”toolbar” tbservices=”compact”]

Javlin invests in healthcare claims that have an extended payment cycle due to complex adjudication processes or litigation—typically diagnostic and non-diagnostic claims, including MRI, Pharmaceuticals, DME, Diagnostics, Shockwave, Interpreting, Psychiatric, Surgery, and PTP.